On October 10, the U.S. Drug Enforcement Agency joined with the Department of Health & Human Services to announce an extension telemedicine flexibilities put in place during the COVID-19 public health emergency. Now through December 31, 2024, authorized providers (see Updates to Requirements for Buprenorphine Prescribing below) can prescribe controlled substances to new and existing patients based on a telephone evaluation, or through other means of telemedicine.
